80 likes | 92 Vues
According to our new research study on "Skin Cancer Diagnostics Market Forecast to 2028 u2013 COVID-19 Impact and Global Analysis u2013 by Type, and Screening Type," the skin cancer diagnostics market size is expected to reach US$ 5,480.45 million by 2028 from US$ 3,364.46 million in 2021; it is estimated to grow at a CAGR of 7.2% from 2021 to 2028. The report highlights trends prevailing in the skin cancer diagnostics market and factors governing its growth. The increasing incidence of skin cancer and launch of new product are driving the growth of the market. However, barriers to early skin cancer d
E N D
Skin Cancer Diagnostics Market Global Analysis and Forecast to 2028 Published Date : Feb 2022 Email: sales@theinsightpartners.com
Email: sales@theinsightpartners.com Report Studies Skin Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Melanoma and Non-melanoma), Screening Type (Blood Tests, Dermatoscopy, Imaging Tests, Lymph Node Biopsy, and Skin Biopsy) 2
Email: sales@theinsightpartners.com Skin Cancer Diagnostics Market Overview The skin cancer diagnostics market is projected to reach US$ 5,480.45 million by 2028 from US$ 3,364.46 million in 2021; it is expected to grow at a CAGR of 7.2% from 2021 to 2028. Skin cancer means abnormal growth of skin cells. It develops in the areas exposed to the sun. Ultraviolet radiation changes the genetic material (DNA) in cells and is the leading cause of skin cancer. Skin cancer is the most common form of cancer. There are two main categories of skin cancer such as melanoma and non-melanoma. Various imaging solutions such as CT scans, MRIs, PET scans, bone scans, and chest X-rays are used to diagnose skin cancer. The skin cancer diagnostics market also includes various diagnostics and therapies related to skin cancer, such as chemotherapy, targeted therapy, immunotherapy, radiotherapy, freezing treatment, and scraping therapy that helps cure skin cancer. 3
Email: sales@theinsightpartners.com Key Segment Market Segment By Type:- By Type (Melanoma and Non-melanoma) Screening Type (Blood Tests, Dermatoscopy, Imaging Tests, Lymph Node Biopsy, and Skin Biopsy) Download Sample Here 4
Email: sales@theinsightpartners.com $50,000 Skin Cancer Diagnostics Market Value $40,000 $30,000 CAGR of 7.2% $20,000 (2021 - 2028) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5
Email: sales@theinsightpartners.com Company Profiles SkylineDx BV AMLo Biosciences Limited NeraCare GmbH DermLite LLC F. HOFFMANN-LA ROCHE LTD bioMerieux SA Veriskin Inc. Castle Biosciences, Inc. DermTech Inc ACS Dobfar S.p.A Michelson Diagnostics Ltd. Download Sample Here 6
Email: sales@theinsightpartners.com By Geography North America (the US, Canada, and Mexico) Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7
THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com